|Mr. Mark C. Throdahl||Pres, CEO & Director||505k||N/A||1951|
|Mr. Fred L. Hite||CFO & Director||472.42k||N/A||1968|
|Mr. Daniel J. Gerritzen||VP of Legal & HR, Gen. Counsel and Sec.||335.72k||N/A||1970|
|Mr. David R. Bailey||Exec. VP||395.5k||N/A||1979|
|Mr. Gregory A. Odle||Exec. VP of Commercialization||395.5k||N/A||1970|
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. It offers trauma and deformity procedures; scoliosis procedures for the treatment of spinal deformity; and sports medicine procedures. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana.
OrthoPediatrics Corp.’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 2; Board: 10; Shareholder Rights: 8; Compensation: 7.